Cargando…
Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide export
Parkinson’s disease (PD) is a progressive neurodegenerative brain disease presenting with a variety of motor and non-motor symptoms, loss of midbrain dopaminergic neurons in the substantia nigra pars compacta and the occurrence of α-synuclein-positive Lewy bodies in surviving neurons. Here, we perfo...
Autores principales: | Martin, Shaun, Smolders, Stefanie, Van den Haute, Chris, Heeman, Bavo, van Veen, Sarah, Crosiers, David, Beletchi, Igor, Verstraeten, Aline, Gossye, Helena, Gelders, Géraldine, Pals, Philippe, Hamouda, Norin Nabil, Engelborghs, Sebastiaan, Martin, Jean-Jacques, Eggermont, Jan, De Deyn, Peter Paul, Cras, Patrick, Baekelandt, Veerle, Vangheluwe, Peter, Van Broeckhoven, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244618/ https://www.ncbi.nlm.nih.gov/pubmed/32172343 http://dx.doi.org/10.1007/s00401-020-02145-7 |
Ejemplares similares
-
Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson’s disease
por: Smolders, Stefanie, et al.
Publicado: (2021) -
ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress
por: Vrijsen, Stephanie, et al.
Publicado: (2020) -
Protection against Mitochondrial and Metal Toxicity Depends on Functional Lipid Binding Sites in ATP13A2
por: Martin, Shaun, et al.
Publicado: (2016) -
ATP13A4 Upregulation Drives the Elevated Polyamine Transport System in the Breast Cancer Cell Line MCF7
por: van Veen, Sarah, et al.
Publicado: (2023) -
The Use of Biomarkers and Genetic Screening to Diagnose Frontotemporal Dementia: Evidence and Clinical Implications
por: Gossye, Helena, et al.
Publicado: (2019)